tradingkey.logo

LifeVantage Corp

LFVN
6.200USD
-0.060-0.96%
Cierre 12/19, 16:00ETCotizaciones retrasadas 15 min
78.68MCap. mercado
7.52P/E TTM

LifeVantage Corp

6.200
-0.060-0.96%

Más Datos de LifeVantage Corp Compañía

LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.

Información de LifeVantage Corp

Símbolo de cotizaciónLFVN
Nombre de la empresaLifeVantage Corp
Fecha de salida a bolsaSep 12, 2012
Director ejecutivoFife (Steven R)
Número de empleados232
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 12
Dirección3300 Triumph Blvd
CiudadLEHI
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal84043
Teléfono18014329000
Sitio Webhttps://www.lifevantage.com/
Símbolo de cotizaciónLFVN
Fecha de salida a bolsaSep 12, 2012
Director ejecutivoFife (Steven R)

Ejecutivos de LifeVantage Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Steven R. Fife, CPA
Mr. Steven R. Fife, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
662.25K
-1.22%
Mr. Michael A. Beindorff
Mr. Michael A. Beindorff
Independent Director
Independent Director
132.63K
+10.43%
Ms. Kristen Cunningham
Ms. Kristen Cunningham
Chief Sales Officer
Chief Sales Officer
132.16K
-1.28%
Mr. Darwin K. Lewis
Mr. Darwin K. Lewis
Independent Director
Independent Director
130.75K
+11.54%
Mr. Raymond B. (Ray) Greer
Mr. Raymond B. (Ray) Greer
Independent Chairman of the Board
Independent Chairman of the Board
112.82K
+13.63%
Ms. Alissa Neufeld
Ms. Alissa Neufeld
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
85.98K
-1.47%
Ms. Cynthia (Cindy) Latham
Ms. Cynthia (Cindy) Latham
Independent Director
Independent Director
64.88K
+26.35%
Mr. Carl Aure
Mr. Carl Aure
Chief Financial Officer
Chief Financial Officer
27.84K
-4.66%
Mr. Rajendran (Raj) Anbalagan
Mr. Rajendran (Raj) Anbalagan
Independent Director
Independent Director
24.00K
+129.26%
Mr. Dayton Judd
Mr. Dayton Judd
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Steven R. Fife, CPA
Mr. Steven R. Fife, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
662.25K
-1.22%
Mr. Michael A. Beindorff
Mr. Michael A. Beindorff
Independent Director
Independent Director
132.63K
+10.43%
Ms. Kristen Cunningham
Ms. Kristen Cunningham
Chief Sales Officer
Chief Sales Officer
132.16K
-1.28%
Mr. Darwin K. Lewis
Mr. Darwin K. Lewis
Independent Director
Independent Director
130.75K
+11.54%
Mr. Raymond B. (Ray) Greer
Mr. Raymond B. (Ray) Greer
Independent Chairman of the Board
Independent Chairman of the Board
112.82K
+13.63%
Ms. Alissa Neufeld
Ms. Alissa Neufeld
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
85.98K
-1.47%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
Por negocioUSD
Nombre
Ganancia
Proporción
Protandim
95.33M
41.71%
Other
84.49M
36.97%
TrueScience
48.71M
21.32%
Por regiónUSD
Nombre
Ganancia
Proporción
Americas
185.72M
81.27%
Asia/Pacific & Europe
42.81M
18.73%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Protandim
95.33M
41.71%
Other
84.49M
36.97%
TrueScience
48.71M
21.32%

Estadísticas de accionistas

Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Capital Management Corporation
16.26%
Renaissance Technologies LLC
6.71%
Sudbury Capital Management, LLC
5.90%
BlackRock Institutional Trust Company, N.A.
5.35%
Fife (Steven R)
5.22%
Otro
60.55%
Accionistas
Accionistas
Proporción
The Capital Management Corporation
16.26%
Renaissance Technologies LLC
6.71%
Sudbury Capital Management, LLC
5.90%
BlackRock Institutional Trust Company, N.A.
5.35%
Fife (Steven R)
5.22%
Otro
60.55%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
41.06%
Individual Investor
17.51%
Hedge Fund
11.17%
Investment Advisor/Hedge Fund
11.06%
Research Firm
0.93%
Family Office
0.65%
Bank and Trust
0.09%
Pension Fund
0.04%
Otro
17.49%

Participación institucional

Actualizado: dom., 5 de oct
Actualizado: dom., 5 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
209
9.12M
71.83%
+954.40K
2025Q2
193
10.05M
79.82%
+1.75M
2025Q1
183
9.39M
74.65%
+1.49M
2024Q4
141
7.17M
57.17%
+9.45K
2024Q3
129
6.84M
54.73%
+709.39K
2024Q2
116
5.82M
46.01%
-208.24K
2024Q1
121
5.85M
45.88%
-259.86K
2023Q4
118
5.82M
45.51%
-198.52K
2023Q3
129
5.88M
46.29%
-614.74K
2023Q2
140
5.48M
43.26%
+523.26K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Capital Management Corporation
2.06M
16.26%
+798.07K
+63.03%
Sep 30, 2025
Renaissance Technologies LLC
894.42K
7.05%
+30.50K
+3.53%
Jun 30, 2025
Sudbury Capital Management, LLC
749.33K
5.9%
--
--
Aug 31, 2025
BlackRock Institutional Trust Company, N.A.
541.66K
4.27%
+343.11K
+172.80%
Jun 30, 2025
Fife (Steven R)
670.43K
5.39%
+71.90K
+12.01%
Aug 31, 2025
The Vanguard Group, Inc.
564.37K
4.45%
+75.44K
+15.43%
Jun 30, 2025
Radoff (Bradley Louis)
551.50K
4.35%
-259.75K
-32.02%
Jul 31, 2024
Dimensional Fund Advisors, L.P.
292.91K
2.31%
+7.29K
+2.55%
Jun 30, 2025
Mauro (Garry Paul)
257.82K
2.03%
+2.55K
+1.00%
Aug 31, 2025
Geode Capital Management, L.L.C.
245.33K
1.93%
+126.27K
+106.06%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Royce Quant Small-Cap Quality Value ETF
0.11%
WisdomTree U.S. SmallCap Dividend Fund
0.03%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Avantis US Small Cap Equity ETF
0.01%
Lattice Hartford Multifactor Small Cap ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
Ver más
Royce Quant Small-Cap Quality Value ETF
Proporción0.11%
WisdomTree U.S. SmallCap Dividend Fund
Proporción0.03%
iShares Micro-Cap ETF
Proporción0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.02%
Avantis US Small Cap Equity ETF
Proporción0.01%
Lattice Hartford Multifactor Small Cap ETF
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%
Franklin US Small Cap Multifactor Index ETF
Proporción0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.01%
Dimensional US Core Equity 1 ETF
Proporción0%

Dividendos

Un total de 10.97M USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Nov 04, 2025
LFVN.NB Interim Cash Dividend of gross USD 0.045 paid on Dec 15, 2025 going ex on Dec 01, 2025
Dec 01, 2025
Dec 15, 2025
Dec 01, 2025
Aug 28, 2025
LFVN.NB Interim Cash Dividend of gross USD 0.045 paid on Sep 16, 2025 going ex on Sep 08, 2025
Sep 08, 2025
Sep 16, 2025
Sep 08, 2025
May 06, 2025
LFVN.NB Interim Cash Dividend of gross USD 0.045 paid on Jun 13, 2025 going ex on May 30, 2025
May 30, 2025
Jun 13, 2025
May 30, 2025
Feb 05, 2025
LFVN.NB Final Cash Dividend of gross USD 0.04 paid on Mar 17, 2025 going ex on Mar 03, 2025
Mar 03, 2025
Mar 17, 2025
Mar 03, 2025
Oct 29, 2024
LFVN.NB Interim Cash Dividend of gross USD 0.04 paid on Dec 16, 2024 going ex on Dec 02, 2024
Dec 02, 2024
Dec 16, 2024
Dec 02, 2024
Aug 28, 2024
LFVN.NB Interim Cash Dividend of gross USD 0.04 paid on Sep 17, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 17, 2024
Sep 09, 2024
May 02, 2024
LFVN.NB Interim Cash Dividend of gross USD 0.04 paid on Jun 14, 2024 going ex on May 31, 2024
May 31, 2024
Jun 14, 2024
May 31, 2024
Jan 30, 2024
LFVN.NB Final Cash Dividend of gross USD 0.035 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 09, 2023
LFVN.NB Interim Cash Dividend of gross USD 0.035 paid on Dec 15, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 15, 2023
Nov 30, 2023
Aug 28, 2023
LFVN.NB Interim Cash Dividend of gross USD 0.035 paid on Sep 22, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 22, 2023
Sep 07, 2023
Ver más

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de LifeVantage Corp?

Los cinco principales accionistas de LifeVantage Corp son:
The Capital Management Corporation posee 2.06M acciones, lo que representa el 16.26% del total de acciones.
Renaissance Technologies LLC posee 894.42K acciones, lo que representa el 7.05% del total de acciones.
Sudbury Capital Management, LLC posee 749.33K acciones, lo que representa el 5.90% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 541.66K acciones, lo que representa el 4.27% del total de acciones.
Fife (Steven R) posee 670.43K acciones, lo que representa el 5.39% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de LifeVantage Corp?

Los tres principales tipos de accionista de LifeVantage Corp son:
The Capital Management Corporation
Renaissance Technologies LLC
Sudbury Capital Management, LLC

¿Cuántas instituciones poseen acciones de LifeVantage Corp (LFVN)?

A fecha de 2025Q3, 209 instituciones poseen acciones de LifeVantage Corp, con un valor de mercado combinado de aproximadamente 9.12M, lo que representa el 71.83% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -7.98%.

¿Cuál es la mayor fuente de ganancias de LifeVantage Corp?

El FY2025, el segmento empresarial Protandim generó la ganancia más alta para LifeVantage Corp, ascendiendo a 95.33M y representando el 41.71% de la ganancia total.
KeyAI